Last Price$84.2(5.1%)
Market Cap$13.9B
LTM Current ratio
1.8x
5Y avg
2.7x
Medical - Diagnostics & Research industry
median
2.0x
Stock quality & Intrinsic value
6/10
0.7% undervalued
Illumina, Inc. Current ratio
Annual
Quarterly
LTM
Industry median
Company stand-alone
Crunching data... Almost there!
| Jan'06 | Dec'06 | Dec'07 | Dec'08 | Jan'10 | Jan'11 | Jan'12 | Dec'12 | Dec'13 | Dec'14 | Jan'16 | Jan'17 | Dec'17 | Dec'18 | Dec'19 | Jan'21 | Jan'22 | Jan'23 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current ratio | 3.7x | 5.7x | 3.4x | 1.7x | 2.2x | 2.4x | 6.5x | 5.9x | 5.0x | 2.6x | 3.4x | 3.3x | 4.0x | 2.5x | 6.7x | 3.6x | 2.5x | 1.3x | 1.7x | 1.8x |
Overvalued or undervalued?
Check the intrinsic value for ILMN
and see if it's the right time to invest.
Illumina, Inc. (ILMN) Current ratio comparison analysis
General
LTM Current ratio
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Illumina, Inc.ILMN
1.8x
(2.9%)
4.6%
(28.0%)
Median Peer Set
1.4x
(0.3%)
(7.2%)
15.2%
Natera, Inc.NTRA
4.4x
32.0%
(32.1%)
(40.2%)
Agilent Technologies, Inc.A
2.2x
(4.7%)
5.0%
19.8%
Thermo Fisher Scientific Inc.TMO
1.7x
(4.6%)
(12.4%)
14.0%
Laboratory Corporation of America HoldingsLH
1.4x
(18.3%)
(65.8%)
3.4%
Danaher CorporationDHR
1.4x
(0.1%)
(17.9%)
16.3%
IDEXX Laboratories, Inc.IDXX
1.3x
8.7%
25.2%
23.1%
Quest Diagnostics IncorporatedDGX
1.1x
(6.4%)
(6.5%)
9.2%
Mettler-Toledo International Inc.MTD
1.0x
2.2%
12.7%
22.3%
IQVIA Holdings Inc.IQV
0.8x
2.8%
2.4%
8.9%
Waters CorporationWAT
N/A
(0.5%)
(7.9%)
21.7%
ILMN key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Jan'06 | Dec'06 | Dec'07 | Dec'08 | Jan'10 | Jan'11 | Jan'12 | Dec'12 | Dec'13 | Dec'14 | Jan'16 | Jan'17 | Dec'17 | Dec'18 | Dec'19 | Jan'21 | Jan'22 | Jan'23 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 73.5 45.3% | 184.6 151.1% | 366.8 98.7% | 573.2 56.3% | 666.3 16.2% | 902.7 35.5% | 1,055.5 16.9% | 1,148.5 8.8% | 1,421.2 23.7% | 1,861.4 31.0% | 2,219.8 19.3% | 2,398.4 8.0% | 2,752.0 14.7% | 3,333.0 21.1% | 3,543.0 6.3% | 3,239.0 (8.6%) | 4,526.0 39.7% | 4,584.0 1.3% | 4,504.0 (1.7%) | 4,372.0 (2.9%) |
| Cost of Goods Sold (COGS) | 23.2 | 59.3 | 132.4 | 205.6 | 205.8 | 301.2 | 346.4 | 375.0 | 509.3 | 563.6 | 670.5 | 731.9 | 926.0 | 1,033.0 | 1,076.0 | 1,036.0 | 1,372.0 | 1,612.0 | 1,760.0 | 1,511.0 |
% margin | 50.3 68.5% | 125.2 67.9% | 234.4 63.9% | 367.6 64.1% | 460.6 69.1% | 601.5 66.6% | 709.1 67.2% | 773.5 67.4% | 911.9 64.2% | 1,297.7 69.7% | 1,549.3 69.8% | 1,666.4 69.5% | 1,826.0 66.4% | 2,300.0 69.0% | 2,467.0 69.6% | 2,203.0 68.0% | 3,154.0 69.7% | 2,972.0 64.8% | 2,744.0 60.9% | 2,861.0 65.4% |
| Operating Expenses | 56.0 | 87.4 | 232.2 | 262.5 | 323.6 | 389.9 | 500.6 | 517.0 | 657.8 | 854.3 | 926.2 | 1,087.4 | 1,220.0 | 1,417.0 | 1,482.0 | 1,623.0 | 3,277.0 | 2,618.0 | 4,010.0 | 3,694.0 |
| Research & Development Expenses (R&D) | 27.7 | 33.4 | 73.9 | 100.0 | 140.6 | 177.9 | 196.9 | 231.0 | 276.7 | 388.1 | 401.5 | 504.4 | 546.0 | 623.0 | 647.0 | 682.0 | 1,185.0 | 1,321.0 | 1,354.0 | 1,169.0 |
| Selling, General & Administrative Expenses (SG&A) | 28.0 | 54.1 | 101.3 | 148.0 | 176.3 | 221.0 | 303.7 | 286.0 | 381.0 | 466.3 | 524.7 | 583.0 | 674.0 | 794.0 | 835.0 | 941.0 | 2,092.0 | 1,297.0 | 1,612.0 | 1,092.0 |
% margin | (21.4) (29.2%) | 37.8 20.5% | (301.2) (82.1%) | 80.5 14.0% | 125.6 18.8% | 211.7 23.4% | 199.5 18.9% | 200.8 17.5% | 134.1 9.4% | 514.7 27.7% | 612.8 27.6% | 587.0 24.5% | 606.0 22.0% | 883.0 26.5% | 985.0 27.8% | 580.0 17.9% | (123.0) (2.7%) | (4,179.0) (91.2%) | (1,069.0) (23.7%) | (833.0) (19.1%) |
| Interest Income | 1.4 | 0.0 | 16.0 | 12.5 | 11.0 | 8.4 | 7.1 | 16.2 | 4.9 | 3.9 | 5.0 | 9.8 | 19.0 | 44.0 | 75.0 | 41.0 | 61.0 | 11.0 | 58.0 | 46.0 |
| Interest Expense | 15.8 | 0.0 | 648.9 | 42.9 | 23.7 | 24.6 | 34.8 | 37.8 | 39.7 | 41.7 | 42.1 | 33.2 | 37.0 | 57.0 | 52.0 | 49.0 | 61.0 | 26.0 | 77.0 | 100.0 |
| Pre-tax Income | (5.6) | 42.6 | (288.8) | 90.9 | 114.1 | 185.4 | 133.0 | 222.6 | 159.3 | 448.8 | 583.1 | 561.2 | 1,043.0 | 894.0 | 1,118.0 | 856.0 | 884.0 | (4,336.0) | (1,117.0) | (1,179.0) |
% effective tax rate | 31.0 (549.4%) | 2.7 6.2% | (10.4) 3.6% | 40.4 44.5% | 41.8 36.7% | 60.5 32.6% | 46.4 34.9% | 71.4 32.1% | 34.0 21.3% | 95.4 21.3% | 125.8 21.6% | 133.1 23.7% | 365.0 35.0% | 112.0 12.5% | 128.0 11.4% | 200.0 23.4% | 122.0 13.8% | 68.0 (1.6%) | 44.0 (3.9%) | 44.0 (3.7%) |
% margin | (20.9) (28.4%) | 40.0 21.7% | (278.4) (75.9%) | 50.5 8.8% | 72.3 10.8% | 124.9 13.8% | 86.6 8.2% | 151.3 13.2% | 125.3 8.8% | 353.4 19.0% | 461.6 20.8% | 462.6 19.3% | 726.0 26.4% | 826.0 24.8% | 1,002.0 28.3% | 656.0 20.3% | 762.0 16.8% | (4,404.0) (96.1%) | (1,161.0) (25.8%) | (1,223.0) (28.0%) |
| EPS | (0.26) | 0.45 | (2.57) | 0.43 | 0.59 | 1.01 | 0.70 | 1.23 | 1.00 | 2.61 | 3.18 | 3.15 | 4.97 | 5.62 | 6.82 | 4.46 | 5.08 | (28.05) | (7.35) | (7.69) |
| Diluted EPS | (0.26) | 0.41 | (2.57) | 0.38 | 0.53 | 0.87 | 0.62 | 1.13 | 0.90 | 2.37 | 3.10 | 3.13 | 4.91 | 5.54 | 6.72 | 4.43 | 5.05 | (28.05) | (7.35) | (7.69) |
% margin | (5.5) (7.5%) | 37.8 20.5% | 18.0 4.9% | 122.6 21.4% | 169.0 25.4% | 252.0 27.9% | 236.1 22.4% | 324.2 28.2% | 363.6 25.6% | 604.7 32.5% | 751.7 33.9% | 735.3 30.7% | 780.0 28.3% | 1,062.0 31.9% | 1,173.0 33.1% | 767.0 23.7% | 747.0 16.5% | (3,916.0) (85.4%) | (608.0) (13.5%) | (725.0) (16.6%) |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Illumina, Inc.'s Current ratio?
As of today, Microsoft Corp's last 12-month Current ratio is 1.8x, based on the financial report for Dec 29, 2024 (Q4’2024). The average annual Current ratio for Illumina, Inc. have been 2.0x over the past three years, and 2.8x over the past five years.
2) Is Illumina, Inc.'s Current ratio Good?
As of today, Illumina, Inc.'s Current ratio is 1.8x, which is lower than industry median of 2.0x. It indicates that Illumina, Inc.'s Current ratio is Bad.